GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senzime AB (OSTO:SEZI) » Definitions » Days Sales Outstanding

Senzime AB (OSTO:SEZI) Days Sales Outstanding : 64.59 (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Senzime AB Days Sales Outstanding?

Senzime AB's average Accounts Receivable for the three months ended in Mar. 2024 was kr8.58 Mil. Senzime AB's Revenue for the three months ended in Mar. 2024 was kr12.12 Mil. Hence, Senzime AB's Days Sales Outstanding for the three months ended in Mar. 2024 was 64.59.

The historical rank and industry rank for Senzime AB's Days Sales Outstanding or its related term are showing as below:

OSTO:SEZI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 23.88   Med: 127.79   Max: 270.88
Current: 69.86

During the past 13 years, Senzime AB's highest Days Sales Outstanding was 270.88. The lowest was 23.88. And the median was 127.79.

OSTO:SEZI's Days Sales Outstanding is ranked worse than
56.75% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 64.92 vs OSTO:SEZI: 69.86

Senzime AB's Days Sales Outstanding increased from Mar. 2023 (60.14) to Mar. 2024 (64.59).


Senzime AB Days Sales Outstanding Historical Data

The historical data trend for Senzime AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senzime AB Days Sales Outstanding Chart

Senzime AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 143.01 113.62 136.64 118.94 65.23

Senzime AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.14 72.02 81.18 71.05 64.59

Competitive Comparison of Senzime AB's Days Sales Outstanding

For the Medical Devices subindustry, Senzime AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Senzime AB's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Senzime AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Senzime AB's Days Sales Outstanding falls into.



Senzime AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Senzime AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (4.21 + 8.569) / 2 ) / 35.754*365
=6.3895 / 35.754*365
=65.23

Senzime AB's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (8.569 + 8.589) / 2 ) / 12.12*365 / 4
=8.579 / 12.12*365 / 4
=64.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Senzime AB  (OSTO:SEZI) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Senzime AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Senzime AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Senzime AB (OSTO:SEZI) Business Description

Traded in Other Exchanges
Address
Ulls vag 41, Uppsala, SWE, 756 51
Senzime AB, a medical technology company, develops, manufactures, and markets patient monitoring systems for monitoring patients. Its solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease healthcare costs. Its product includes TetraGraph and TetraSens, ExSpiron, TetraSens Pediatric, and TetraConnect. Its geographical segments include Sweden, the United States, Europe/Oceania, and Asia.

Senzime AB (OSTO:SEZI) Headlines

No Headlines